Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07395583Not ApplicableRecruiting

Preventing Non-Contact Hamstring Injuries in Elite Footballers: Eccentric vs Concentric Training

Role: lead

NCT07115316Not ApplicableRecruiting

EFFECTIVENESS OF ECCENTRIC HAMSTRING CONTRACTIONS WITH PHYSIOTHERAPY TRAINING ON SPORTS PERFORMANCE AND QUALITY OF LIFE IN YOUNG MALE FOOTBALL PLAYERS WITH NON-CONTACT GRADE 1 ACL INJURY

Role: lead

NCT06135948Phase 4Completed

Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism

Role: lead

NCT05705388Not ApplicableUnknown

POSE2.0 With GLP-1 Agonist for Obesity Management

Role: lead

NCT05611567Not ApplicableCompleted

Endoscopic Gastric Plication Using the POSE2.0 Technique for Management of Fatty Liver Disease

Role: lead

NCT05144178Unknown

Insight Into the UAE Experience With Monoclonal Antibodies (Sotrovimab )

Role: lead

All 6 trials loaded